DOCTOR ZONE
Doctor Zone
Salvage Radiation Therapy
Our salvage radiation therapy nomogram predicts whether a recurrence of prostate cancer after radical prostatectomy can be treated successfully with salvage radiation therapy (external-beam radiation given after the prostate cancer returns). It calculates the probability that cancer will be controlled and PSA level undetectable six years after salvage therapy. You can use this nomogram for applicable results if your post-radical prostatectomy serum PSA level was at first undetectable (less than 0.05 ng/mL) and then rose steadily, indicating a recurrence.
Results produced by this tool are based on studies conducted at large research institutions with physicians who perform a high volume of prostate cancer procedures. All results must be understood in the context of each patient’s specific treatment plan. Patients and caregivers using this tool should discuss the result with the patient’s physician.
To gather the information required to use this nomogram,
If you are a patient, print the Salvage Radiation Therapy Worksheet and bring it with you to your next appointment. The worksheet contains a list of what you need to use this prediction tool.
From the Memorial Sloan Kettering Cancer Center website
PSA Doubling Time
This tool can be used to calculate the rate of rise of PSA, expressed as the velocity in nanograms/mL/year, or the PSA doubling time, in months or years.
If you are a patient, print the PSA Doubling Time Worksheet and bring it with you to your next appointment. The worksheet contains a list of what you need to use this prediction tool.
From the Memorial Sloan Kettering Cancer Center website
Pre-Radical Prostatectomy
Our pre-radical prostatectomy nomogram is for patients diagnosed with prostate cancer who have not yet begun treatment. This nomogram predicts the extent of cancer and long-term results following radical prostatectomy (surgery to remove the prostate gland and surrounding lymph nodes). Using a dynamic statistical formula, this nomogram draws on data from more than 10,000 prostate cancer patients.
If you are a patient, print the PSA Doubling Time Worksheet and bring it with you to your next appointment. The worksheet contains a list of what you need to use this prediction tool.
From the Memorial Sloan Kettering Cancer Center website
Post-Radical Prostatectomy
Our post-radical prostatectomy nomogram can be used by patients after their surgical treatment for prostate cancer. Using a dynamic statistical formula, this nomogram predicts the probability of remaining cancer recurrence-free at two, five, seven, and ten years following surgery. This nomogram also predicts 15-year cancer-specific survival, meaning the likelihood that you will NOT die of prostate cancer within 15 years following surgery.
If you are a patient, print the Post-Radical Prostatectomy Worksheet and bring it with you to your next appointment. The worksheet contains a list of what you need to use this prediction tool.
From the Memorial Sloan Kettering Cancer Center website
Prostate Cancer Risk Calculator
The Prostate Cancer Risk Calculator has been designed to help you, and the health professionals looking after you. There are eight different calculators and the first two are designed for individual use without any medical knowledge.
From the SWOP, The Prostate Cancer Research Foundation, Reeuwijk website
Risk of Dying of Prostate Cancer
This nomogram can be used by patients to estimate the risk of dying of prostate cancer if their cancer recurs, signaled by a rising PSA, after radical prostatectomy. The nomogram predicts the likelihood, in a man initially treated with surgery, that he will die of prostate cancer five, ten, and 15 years from the time his PSA begins to rise.
If you are a patient, print the Risk of Dying of Prostate Cancer in Men With a Rising PSA After Radical Prostatectomy Worksheet and bring it with you to your next appointment. The worksheet contains a list of what you need to use this prediction tool.
From the Memorial Sloan Kettering Cancer Center website
Charlson Comorbidity Index (CCI)
Predicts 10-year survival in patients with multiple comorbidities.
From the MDCalc website